Gilead Sciences, US3755581036

Gilead Sciences stock slips 0.85 percent ahead of the open

Published on 09/24/2026 at 07:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Gilead Sciences stock stood at USD 151.37 on Nasdaq, down 0.85 percent, while the Nasdaq Composite fell 1.13 percent. The next earnings date is October 22, 2026.

Photorealistischer Biotech-Campus von Gilead Sciences mit Glaslabor und Wissenschaftlern
Gilead Sciences Forschungscampus mit ISIN US3755581036 modernes Biopharma-Labor Kalifornien Glasfassade Wissenschaftler arbeiten, Illustration mit AI erstellt.

Gilead Sciences stock closed at USD 151.37 on Nasdaq on September 23, 2026, down 0.85 percent from the prior session. The Nasdaq Composite fell 1.13 percent to 26,936, giving the stock a 0.28 percentage point relative performance advantage.

September 23, 2026 in numbers

Gilead Sciences, Inc. (ISIN US3755581036, Nasdaq: GILD) traded between USD 148.71 and USD 150.56 in the prior Nasdaq session, according to the dated market report. Nasdaq data showed volume of 937 million USD for the session and a close of USD 151.37 on September 23, 2026.

Market conditions were broadly weaker as the Nasdaq Composite lost 1.13 percent and the S&P 500 declined 0.75 percent on September 23, 2026. The broader market review linked the decline to higher Treasury yields, stronger economic data and renewed expectations for additional Federal Reserve rate increases.

Next earnings date on October 22

Gilead Sciences is scheduled to report its next earnings on October 22, 2026, according to AD HOC NEWS. A separate earnings calendar lists October 29, 2026 as an estimated release date, creating a dated calendar discrepancy.

Disclaimer...

en | US3755581036 | GILEAD SCIENCES | boerse | 70174495 | bgmi